EdgarLookup

Vivid Seats Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Vivid Seats Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Financials Insiders
178.9%
Profit Margin
Net income ÷ revenue
126.6%
Return on Assets
Net income ÷ assets
-8.48x
Debt-to-Equity
Total liabilities ÷ equity
-30.5%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $450.51M Mar 12, 2026
FY2025 Dec 31, 2024 $647.89M Mar 12, 2026
FY2025 Dec 31, 2023 $597.39M Mar 12, 2026
FY2024 Dec 31, 2022 $511.09M Mar 12, 2025
FY2023 Dec 31, 2021 $389.67M Mar 8, 2024
FY2022 Dec 31, 2020 $23.28M Mar 7, 2023
FY2021 Dec 31, 2019 $403.65M Mar 15, 2022

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $806.05M Mar 12, 2026
FY2025 Dec 31, 2024 $13.43M Mar 12, 2026
FY2025 Dec 31, 2023 $69.42M Mar 12, 2026
FY2024 Dec 31, 2022 $70.79M Mar 12, 2025
FY2022 Dec 31, 2021 ($5.02M) Mar 7, 2023

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $636.87M Mar 12, 2026
FY2025 Dec 31, 2024 $1.64B Mar 12, 2026
FY2024 Dec 31, 2023 $1.55B Mar 12, 2025
FY2023 Dec 31, 2022 $1.15B Mar 8, 2024
FY2022 Dec 31, 2021 $1.41B Mar 7, 2023

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $722.00M Mar 12, 2026
FY2025 Dec 31, 2024 $1.02B Mar 12, 2026
FY2024 Dec 31, 2023 $963.34M Mar 12, 2025

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($85.13M) Mar 12, 2026
FY2025 Dec 31, 2024 $261.11M Mar 12, 2026
FY2024 Dec 31, 2023 $105.02M Mar 12, 2025
FY2023 Dec 31, 2022 ($382.70M) Mar 8, 2024

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2023 16 Mar 12, 2026

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2024 1 Mar 12, 2026
FY2025 Dec 31, 2023 5 Mar 12, 2026

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $102.70M Mar 12, 2026
FY2025 Dec 31, 2024 $243.48M Mar 12, 2026
FY2024 Dec 31, 2023 $125.48M Mar 12, 2025
FY2023 Dec 31, 2022 $251.54M Mar 8, 2024
FY2022 Dec 31, 2021 $489.53M Mar 7, 2023

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $383.43M Mar 12, 2026
FY2025 Dec 31, 2024 $384.96M Mar 12, 2026
FY2024 Dec 31, 2023 $264.63M Mar 12, 2025
FY2023 Dec 31, 2022 $264.90M Mar 8, 2024
FY2022 Dec 31, 2021 $460.13M Mar 7, 2023
FY2021 Dec 31, 2020 $870.90M Mar 15, 2022